Stock Price Quote

BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE337.80-1.85 (-0.54 %)
PREV CLOSE ( ) 339.65
OPEN PRICE ( ) 340.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 37093
TODAY'S LOW / HIGH ( )336.65 343.80
52 WK LOW / HIGH ( )314.9 420.25
NSE338.05-1.95 (-0.57 %)
PREV CLOSE( ) 340.00
OPEN PRICE ( ) 342.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 338.05 (39)
VOLUME 1242086
TODAY'S LOW / HIGH( ) 336.35 343.80
52 WK LOW / HIGH ( )314.8 420.25
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 29-11 1978
Management Info
Kiran Mazumdar-Shaw - Chairman Siddharth Mittal - Managing Director
Registered Office

Address 20th Km,Hosur Road,Electronic City,
Bengaluru,
Karnataka-560100

Phone 080 2808 2808

Email corporate.communications@biocon.com

Website www.biocon.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

20May Biocon zooms as its arm, Viatris launc
Biocon is currently trading at Rs. 340.05, up by 17.10 points or 5.29% f..
20May Hero MotoCorp, Biocon and Wipro to see
Reaffirming its commitment to an exciting and comprehensive product port..
19May Biocon’s arm, Viatris launch third Onc
Biocon’s subsidiary -- Biocon Biologics and Viatris Inc. have launched A..
29Apr Biocon reports 19% fall in Q4 consolid
Biocon has reported results for fourth quarter and year ended March 31,..
26Apr Biocon’s step down subsidiary bags con
Biocon’s subsidiary -- Biocon Biologics’ arm Biocon Sdn. Bhd. in Malaysi..

Financials

in Millions
QTR Mar 22 ANNUAL 22
Net Profit381861
Gross Profit 592 1397
Operating Profit 8732483
Net Sales 517717382

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  2648.00 (3.33%)
M.Cap ( in Cr)6620.00
Pfizer (BSE)
peergroup  4407.35 (1.27%)
M.Cap ( in Cr)20162.63
Sanofi India (BSE)
peergroup  6636.45 (0.82%)
M.Cap ( in Cr)15284.16
Dr. Reddy's Lab (BSE)
peergroup  4274.25 (0.66%)
M.Cap ( in Cr)71134.57
Kwality Pharma (BSE)
peergroup  397.25 (5.00%)
M.Cap ( in Cr)412.19

Shareholding Pattern

PROMOTERS 60.64%
FI/BANKS/INSURANCE 4.27%
MUTUAL FUNDS/UTI 3.52%
NON-INSTITUTION 15.39%
GOVERNMENT 0%
FII 0%

About Biocon Ltd.

Biocon Ltd. was incorporated in the year 1978. Its today's share price is 337.8. Its current market capitalisation stands at Rs 40556.27 Cr. In the latest quarter, company has reported Gross Sales of Rs. 20284 Cr and Total Income of Rs.21799 Cr. The company's management includes Naina Lal Kidwai, Mayank Verma, Mary Harney, Daniel Mark Bradbury, Vijay Kumar Kuchroo, Bobby Kanubhai Parikh, Meleveetil Damodaran, Ravi Mazumdar, Siddharth Mittal, Kiran Mazumdar-Shaw.

It is listed on the BSE with a BSE Code of 532523 , NSE with an NSE Symbol of BIOCON and ISIN of INE376G01013. It's Registered office is at 20th Km,Hosur Road,Electronic CityBengaluru-560100, Karnataka. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, SR Batliboi & Associates, SR Batliboi & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)